Overview

The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The study is being done to compare the safety and effects (good and bad) of three different combinations of immunosuppression drugs used by kidney transplant recipients while also looking at their kidney function.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Everolimus
Sirolimus